Evidence map›Paper›PMID 27630236›Full record

ArticleJournal of virology2016

A Library of Infectious Hepatitis C Viruses with Engineered Mutations in the E2 Gene Reveals Growth-Adaptive Mutations That Modulate Interactions with Scavenger Receptor Class B Type I.

Adam Zuiani, Kevin Chen, Megan C Schwarz, James P White, Vincent C Luca, Daved H Fremont, David Wang, Matthew J Evans, Michael S Diamond

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Adam ZuianiDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
Kevin ChenDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Megan C SchwarzDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
James P WhiteDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
Vincent C LucaDepartments of Molecular and Cellular Physiology and Structural Biology and the Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, California, USA.
Daved H FremontDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
David WangDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
Matthew J EvansDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Michael S DiamondDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA diamond@borcim.wustl.edu.
Washington University in St. Louis · USIcahn School of Medicine at Mount Sinai · USHoward Hughes Medical Institute · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Hepatitis C virus polarized cell entry pathwaysR01DK095125 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI EVANS, MATTHEW J · 2012 to 2016
$1.8M
NCATS NIH HHS UL1 TR000448NCI NIH HHS P30 CA091842NIDDK NIH HHS R01 DK095125
6 · The paper itself

Abstract

While natural hepatitis C virus (HCV) infection results in highly diverse quasispecies of related viruses over time, mutations accumulate more slowly in tissue culture, in part because of the inefficiency of replication in cells. To create a highly diverse population of HCV particles in cell culture and identify novel growth-enhancing mutations, we engineered a library of infectious HCV with all codons represented at most positions in the ectodomain of the E2 gene. We identified many putative growth-adaptive mutations and selected nine highly represented E2 mutants for further study: Q412R, T416R, S449P, T563V, A579R, L619T, V626S, K632T, and L644I. We evaluated these mutants for changes in particle-to-infectious-unit ratio, sensitivity to neutralizing antibody or CD81 large extracellular loop (CD81-LEL) inhibition, entry factor usage, and buoyant density profiles. Q412R, T416R, S449P, T563V, and L619T were neutralized more efficiently by anti-E2 antibodies and T416R, T563V, and L619T by CD81-LEL. Remarkably, all nine variants showed reduced dependence on scavenger receptor class B type I (SR-BI) for infection. This shift from SR-BI usage did not correlate with a change in the buoyant density profiles of the variants, suggesting an altered E2-SR-BI interaction rather than changes in the virus-associated lipoprotein-E2 interaction. Our results demonstrate that residues influencing SR-BI usage are distributed across E2 and support the development of large-scale mutagenesis studies to identify viral variants with unique functional properties. IMPORTANCE: Characterizing variant viruses can reveal new information about the life cycle of HCV and the roles played by different viral genes. However, it is difficult to recapitulate high levels of diversity in the laboratory because of limitations in the HCV culture system. To overcome this limitation, we engineered a library of mutations into the E2 gene in the context of an infectious clone of the virus. We used this library of viruses to identify nine mutations that enhance the growth rate of HCV. These growth-enhancing mutations reduced the dependence on a key entry receptor, SR-BI. By generating a highly diverse library of infectious HCV, we mapped regions of the E2 protein that influence a key virus-host interaction and provide proof of principle for the generation of large-scale mutant libraries for the study of pathogens with great sequence variability.

Indexed as

MutationAdaptation, PhysiologicalAmino Acid SubstitutionAntibodies, ViralCell LineCRISPR-Cas SystemsGene LibraryGenetic EngineeringGenome, ViralHepacivirusHepatitis CHost-Pathogen InteractionsHumansModels, MolecularMutagenesis, Site-DirectedScavenger Receptors, Class BAntibodies, ViralCD81 protein, humanglycoprotein E2, Hepatitis C virusSCARB1 protein, humanScavenger Receptors, Class BTetraspanin 28Viral Envelope Proteins

Identifiers

PMID27630236
PMCPMC5110168
OpenAlexW2519857486

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.